TOPIC : ERA-NET Cofund on Biotechnologies
|Publication date:||14 October 2015|
|Types of action:||ERA-NET-Cofund ERA-NET Cofund|
|DeadlineModel: Opening date:||single-stage 15 October 2015||Deadline:||21 January 2016 17:00:00|
|Time Zone : (Brussels time)|
Topic DescriptionSpecific Challenge:
During the last two decades major progress was made in terms of industrial applications of biotechnology. Relevant national and FP7 research programmes and projects in the Biotechnology area have significantly contributed to improve European economic and environmental protection. Innovation in biotechnology also provides opportunities to transform the global economy from an extensive dependence on fossil raw material to a sustainable “bio-economy”.
However, economic indicators suggest a need for urgent action to maintain Europe’s global lead in biotechnology. In order to increase the competitiveness of EU industries, broader and deeper collaboration across relevant sectors and Member States is necessary. It will also be necessary to better use research advances in areas such as systems and synthetic biology for applications and demonstration in industrial biotechnology.Scope:
Proposals should gather a critical number of relevant programme managers and funders in the field, and implement a joint transnational call for proposals (resulting in grants to third parties) with EU co-funding, focusing on Technology Readiness Levels in the range of 3 to 6. They should build on the previous success of ERA-IB-2, ERASysAPP, ERASynBio under FP7, allowing for the seamless integration of the areas covered, together with the bioinformatics area and be complementary to related health initiatives. The ultimate aim is to speed-up research and innovation in industrial biotechnology, establishing systems biology and synthetic biology as technology drivers while focusing on downstream industrial applications. The significant involvement of industry in the activities developed up to the exploitation of results will be an important element to achieve this goal. Extensive communication activities should foster the European leadership role in advanced biotechnological research and innovation.
The proposals will address Social Sciences and Humanities (SSH) elements, in particular for outreach activities and in terms of the public perception of biotechnologies for industrial uses.
The Commission considers that proposals requesting a contribution from the EU between EUR 8 and 10 million would allow this specific challenge to be addressed appropriately. Nonetheless, this does not preclude submission and selection of proposals requesting other amounts.
No more than one action will be funded.Expected Impact:
- Better align current EU and national biotechnology initiatives with the goals of the KET Biotechnology area under Horizon 2020, in particular by focusing on application-oriented research and demonstration activities and by developing a European Biotechnology hub, acting as a facilitator and multiplier in this regard.
- Improved use of synergies and coherence of current research funding activities in particular through the launch of calls for proposals and the use of existing research infrastructures (e.g. bioinformatics).
- Increase the financial commitment of participating countries and additional private sector resources compared to the three previous ERA-NET projects.
- Increase the visibility of the potential benefits of a bio-based economy for the society, in particular through dissemination and exploitation of results.
Topic conditions and documents
Please read carefully all provisions below before the preparation of your application.
- LIST OF COUNTRIES and APPLICABLE RULES FOR FUNDING
described in part A of the General Annexes of the General Work Programme.
Note also that a number of non-EU/non-Associated Countries that are not automatically eligible for funding have made specific provisions for making funding available for their participants in Horizon 2020 projects (follow the links to China, Japan, Republic of Korea, Mexico, Russia, Taiwan).
- ELIGIBILITY and ADMISSIBILITY CONDITIONS
described in part B and C of the General Annexes of the General Work Programme.
Proposal page limits and layout: Please refer to Part B of the standard proposal template.
3.1 Evaluation criteria and procedure, scoring and threshold: described in part H of the General Annexes of the General Work Programme , with the following exceptions:
For single-stage and second-stage evaluations, the threshold for the criteria Excellence and Impact will be 4.
The overall threshold, applying to the sum of the three individual scores, will be 12.
In case of equal overall scores in the ranked list, the priority order of proposals will be established in accordance with part H of the General Annexes, except that proposals will be ranked on the basis of individual scores for the Impact criterion before the Excellence criterion.
In case of equal overall scores in the ranked list, the priority order of proposals will be established in accordance with part H of the General Annexes, except, when comparing ex aequo proposals of different topics, the proposals will be ranked first according to the position in the topic ranked lists
3.2 Submission and evaluation process: Guide to the submission and evaluation process
- INDICATIVE TIMETABLE for EVALUATION and GRANT AGREEMENT
Information on the outcome of single-stage evaluation: maximum 5 months from the deadline for submission.
Signature of grant agreements: maximum 8 months from the deadline for submission.
- PROVISIONS, PROPOSAL TEMPLATES and EVALUATION FORMS
for the type of action under this topic
Specific provisions and funding rates
Standard proposal template
Standard evaluation form
H2020 MGA ERANET Cofund - Multi-Beneficiary
Annotated Grant Agreement
- ADDITIONAL PROVISIONS
Horizon 2020 budget flexibility
Technology readiness levels (TRL) – where a topic description refers to TRL, these definitions apply.
Financial support to Third Parties – where a topic description foresees financial support to Third Parties, these provisions apply.
- OPEN ACCESS
must be granted to all scientific publications resulting from Horizon 2020 actions, and proposals must refer to measures envisaged.
Where relevant, proposals should also provide information on how the participants will manage the research data generated and/or collected during the project, such as details on what types of data the project will generate, whether and how this data will be exploited or made accessible for verification and re-use, and how it will be curated and preserved.
- ADDITIONAL DOCUMENTS
Legal basis: Horizon 2020 - Regulation of Establishment
Legal basis: Horizon 2020 Rules for Participation
Legal basis: Horizon 2020 Specific Programme
H2020 Work Programme 2016-17: Introduction
H2020 Work Programme 2016-17: Introduction to Leadership in enabling and industrial technologies (LEITs)
H2020 Work Programme 2016-17: Nanotechnologies, advanced materials, advanced manufacturing and processing, biotechnology
H2020 Work Programme 2016-17: Cross-cutting activities (Focus Areas)
H2020 Work Programme 2016-17: Dissemination, Exploitation and Evaluation
H2020 Work Programme 2016-17: General Annexes
- 2016 SINGLE STAGE FLASH CALL INFO en
No submission system is open for this topic.
National Contact Points (NCP) - contact your NCP for further assistance.
Enterprise Europe Network – contact your EEN national contact for advice to businesses with special focus on SMEs. The support includes guidance on the EU research funding.
Partner Search Services help you find a partner organisation for your proposal.
Research Enquiry Service – ask questions about any aspect of European research in general and the EU Research Framework Programmes in particular.
H2020 Online Manual your online guide on the procedures from proposal submission to managing your grant.
Participant Portal FAQ – Submission of proposals.
IT Helpdesk- contact the Participant Portal IT helpdesk for questions such as forgotten passwords, access rights and roles, technical aspects of submission of proposals, etc.
European IPR Helpdesk assists you on intellectual property issues